Free Trial

Beam Therapeutics (BEAM) SEC Filings & 10K Form

Beam Therapeutics logo
$20.75 +0.30 (+1.47%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$20.70 -0.05 (-0.26%)
As of 07/18/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Beam Therapeutics SEC Filings

DateFilerForm TypeView
07/03/2025
4:30 PM
Beam Therapeutics (Issuer)
Simon Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
3:30 PM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
6:05 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2025
6:30 AM
Beam Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/10/2025
8:36 AM
Beam Therapeutics (Issuer)
FMR LLC (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/03/2025
8:50 PM
Beam Therapeutics (Issuer)
Simon Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
8:50 PM
Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
8:51 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
8:52 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/03/2025
8:53 PM
Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
6:11 PM
Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
6:13 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
6:18 PM
Beam Therapeutics (Issuer)
Simon Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
6:21 PM
Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
6:10 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2025
10:02 AM
Beam Therapeutics (Subject)
FMR LLC (Filed by)
Form SCHEDULE 13G/A
03/31/2025
5:43 PM
Beam Therapeutics (Subject)
Ciaramella Giuseppe (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/31/2025
5:43 PM
Beam Therapeutics (Subject)
Bellon Christine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/31/2025
5:43 PM
Beam Therapeutics (Subject)
Evans John M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/31/2025
5:44 PM
Beam Therapeutics (Subject)
Simon Amy (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
4:23 PM
Beam Therapeutics (Filer)
Form 424B5
03/10/2025
4:02 PM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2025
5:10 AM
Beam Therapeutics (Filer)
Form 424B5
03/10/2025
5:13 AM
Beam Therapeutics (Subject)
Form FWP
03/10/2025
5:06 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2025
6:51 AM
Beam Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/25/2025
6:30 AM
Beam Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2025
6:19 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
3:10 PM
Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
6:30 PM
Beam Therapeutics (Subject)
Farallon Capital Partners, L.P. (Filed by)
Form SCHEDULE 13G/A
02/03/2025
3:05 PM
Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:05 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:05 PM
Beam Therapeutics (Issuer)
Simon Amy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:05 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:05 PM
Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
3:12 PM
Beam Therapeutics (Subject)
Evans John M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
6:05 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
8:46 PM
ARK Investment Management LLC (Filed by)
Beam Therapeutics (Subject)
Form SCHEDULE 13G/A
01/06/2025
4:48 PM
Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:49 PM
Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
7:04 PM
Beam Therapeutics (Issuer)
Emany Sravan Kumar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom (Ad)

Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.

Click here to see the details on what could be the biggest tech story of this decade.
12/30/2024
6:26 PM
Beam Therapeutics (Subject)
Bellon Christine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/30/2024
6:29 PM
Beam Therapeutics (Subject)
Cavanagh Bethany J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/19/2024
3:10 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
6:01 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
6:06 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2024
6:18 AM
Beam Therapeutics (Issuer)
Guindo Chirfi (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/04/2024
6:22 AM
Beam Therapeutics (Issuer)
Guindo Chirfi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/04/2024
6:08 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
3:10 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2024
8:56 AM
Beam Therapeutics (Subject)
Farallon Capital Partners, L.P. (Filed by)
Form SC 13G/A
11/05/2024
8:00 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
8:06 AM
Beam Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2024
7:30 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
6:05 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
10:50 AM
Beam Therapeutics (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
10/16/2024
3:44 PM
Beam Therapeutics (Issuer)
Ciaramella Giuseppe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
10:37 AM
Beam Therapeutics (Subject)
Ciaramella Giuseppe (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/07/2024
4:00 PM
Beam Therapeutics (Subject)
Burrell Terry-Ann (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/02/2024
4:51 PM
Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:52 PM
Beam Therapeutics (Issuer)
Bellon Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
4:49 PM
Beam Therapeutics (Issuer)
Evans John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:51 PM
Beam Therapeutics (Subject)
Evans John M. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
3:15 PM
Beam Therapeutics (Issuer)
Cavanagh Bethany J (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/06/2024
6:08 AM
Beam Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BEAM) was last updated on 7/20/2025 by MarketBeat.com Staff
From Our Partners